Ascend Loses Another $17M, Slows Losses by Expanding Footprint

Year-to-date losses were lower than at the same time in 2021.

New York-based Ascend Wellness Holdings Inc. (CSE: AAWH.U) (OTCQX: AAWH) posted a $16.8 million loss for the third quarter of 2022, even as it expanded its footprint through several Midwest markets and launched recreational sales in New Jersey.

Ascend so far has lost $65.8 million for the year, as of Sept. 30, but that’s down from 2021, when Ascend posted a $106 million loss for the first nine months.

Executive Chairman Abner Kurtin – who made headlines for assault charges filed and then dropped against him in Florida this past quarter – touted the company’s increased revenue and growth in both retail and wholesale markets, but acknowledged “challenging macro- and microenvironments” in the national cannabis industry.

Net revenue increased 14.1% from the second quarter to $111.2 million – for a total of net revenue year-to-date of $293.8 million – primarily due to “an increase in third-party wholesale sales, the conversion of retail stores to adult-use, and new store openings,” the company said in a news release.

Highlights of the company’s expansion include:

  • In New Jersey, Ascend began recreational cannabis sales at one store, opened a second medical-only dispensary in another city, and launched operations at a new manufacturing facility.
  • In Ohio, it acquired Ohio Patient Access, which will allow it to open another trio of medical dispensaries in the state, for a total of five, the maximum allowed for any business.
  • In Illinois, Ascend also acquired two more cannabis stores which are yet to be fully built out, but which will bring its retail presence in the state to 10 shops, again hitting another state cap on retail outlets.

After the quarter came to an end, Ascend continued construction of a new 6,000-square-foot cultivation facility in Pennsylvania, which it hopes will be operational by the end of the year. It also opened a so-called “outlet” dispensary in Scranton.

John Schroyer

John Schroyer has been a reporter since 2006, initially with a focus on politics, and covered the 2012 Colorado campaign to legalize marijuana. He has written about the cannabis industry specifically since 2014, after being on hand for the first-ever legal cannabis sales on New Year’s Day that year in Denver. John has covered subsequent marijuana market launches in California and Illinois, has written about every aspect of the marijuana trade, and was part of the team that built the cannabis industry’s first-ever trade show, MJBizCon. He joined Green Market Report in 2022.


  • John Pinto

    November 10, 2022 at 7:40 pm

    This piece is very misleading. Ascend was about the only MSO to grow revenue and ebitda double digits Q4/Q3 and also the only one to solidly beat consensus on both metrics, and provide a solid outlook, yet you do a hit job?


    • John Pinto

      November 10, 2022 at 7:42 pm

      Correction, Q3/Q2. I am also fine if you don’t publish the above and happy to just discuss.


Leave a Reply

Your email address will not be published. Required fields are marked *

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.

 Sign up

About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


Recent Tweets

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.